A Multiple Dose Study To Determine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP05195 in Healthy Adult Subjects.

Trial Profile

A Multiple Dose Study To Determine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP05195 in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2013

At a glance

  • Drugs DWP 05195 (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Feb 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 08 Feb 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top